Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension
Caroline M. Daly(Johns Hopkins University), Allen D. Everett(Johns Hopkins University), Rachel L. Damico, Melanie Nies(Johns Hopkins University), Pei‐Ni Jone(Northwestern University), D. Dunbar Ivy(University of Colorado Denver), Stephanie Brandal(Johns Hopkins University), Eric D. Austin(Vanderbilt University), Cassandra Polsen(Children's Hospital Colorado), Delphine Yung, Russel Hirsch(National Heart Institute), William C. Nichols(Cincinnati Children's Hospital Medical Center), Megan Griffiths(Southwestern Medical Center), Jun Yang(May Institute), Dhananjay Vaidya(Unknown), Michael W. Pauciulo(Center for Human Genetics), Erika B. Rosenzweig(New York Medical College), Mónica Williams, Catherine E. Simpson(Johns Hopkins University), Katie A. Lutz(Center for Human Genetics)
Cited by 11
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
|Circulation Research|2001|686
Hypoplastic Left Heart Syndrome
|Journal of the American College of Cardiology|2011|498
NGAL is an early predictive biomarker of contrast-induced nephropathy in children
|Pediatric Nephrology|2007|459
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
|Human Genetics|2008|444